Tyra Biosciences Inc
(TYRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 32,944 | 31,452 | 31,850 | 29,719 | 28,604 |
| Operating Income | -32,944 | -31,452 | -31,850 | -29,719 | -28,604 |
| Other Income | 3,076 | 3,354 | 3,703 | 4,148 | 4,588 |
| Pre-tax Income | -29,868 | -28,098 | -28,147 | -25,571 | -24,016 |
| Net Income Continuous | -29,868 | -28,098 | -28,147 | -25,571 | -24,016 |
| Net Income | $-29,868 | $-28,098 | $-28,147 | $-25,571 | $-24,016 |
| EPS Basic Total Ops | -0.50 | -0.47 | -0.47 | -0.43 | -0.41 |
| EPS Basic Continuous Ops | -0.50 | -0.47 | -0.47 | -0.44 | -0.41 |
| EPS Diluted Total Ops | -0.50 | -0.47 | -0.47 | -0.43 | -0.41 |
| EPS Diluted Continuous Ops | -0.50 | -0.47 | -0.47 | -0.44 | -0.41 |
| EPS Diluted Before Non-Recurring Items | -0.50 | -0.47 | -0.47 | -0.43 | -0.41 |
| EBITDA(a) | $-32,813 | $-31,312 | $-31,707 | $-29,575 | $-28,477 |